Saturday, July 25, 2026

pharma · Generalized Pustular Psoriasis · Schizophrenia · VNDA

Vanda Pharmaceuticals Netherlands

Vanda Pharmaceuticals Netherlands trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037, US HQ
2003 Founded
600 Employees
Public company Type
VNDA · NYSE Ticker
Company details
Status
Public
HQ
2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037, US
Founded
2003
Employees
600
Programs
4
Drugs
9
Patents
56
Intelligence · Clinical Trials

Vanda Pharmaceuticals Netherlands clinical trials

Registry index of 8 ClinicalTrials.gov studies linked to Vanda Pharmaceuticals Netherlands programs — each row shows trial ID, program name, phase, status, and indication.

Vanda Pharmaceuticals Netherlands trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Vanda Pharmaceuticals Netherlands.

  1. Iloperidone crystalline formulation — Phase 2

    Clinical update
  2. Tradipitant — Phase 2

    Clinical update
  3. VHX-896 and iloperidone — Phase 1

    Clinical update
  4. Iloperidone — Approved

    Clinical update

Trial registry

8 studies